Allurion Technologies Q2 EPS $(0.05) Beats $(0.24) Estimate, Sales $11.77M Beat $10.90M Estimate
Portfolio Pulse from Benzinga Newsdesk
Allurion Technologies reported a Q2 EPS of $(0.05), beating the estimate of $(0.24). Sales were $11.77M, surpassing the $10.90M estimate.
August 13, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Allurion Technologies reported better-than-expected Q2 results with an EPS of $(0.05) and sales of $11.77M, beating estimates of $(0.24) and $10.90M respectively.
The better-than-expected EPS and sales figures indicate strong performance, likely boosting investor confidence and positively impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100